Skip to main content
. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474

Table 1.

Clinical and sociodemographic data (N = 242)

  Frequency (%)
Age
Median (SD)
65.00 y (8.3y)
 
Range
40-84y
Marital status
Single
18 (8.4%)
 
Partnership, marriage
135 (63.1%)
 
Divorced, separated
28 (13.1%)
 
Widowed
33 (15.4%)
Employment status
Full-time
16 (7.5%)
 
Part-time
16 (7.5%)
 
Unemployed
5 (2.1%)
 
Homemaker
31 (14.5%)
 
Retired
142 (66.4%)
 
Other
4 (1.6%)
Histological classification
Invasive
226 (93.4%)
 
In situ
15 (6.2%)
 
Missing
1 (0.4%)
Grading
Grade I
35 (14.5%)
 
Grade II
176 (72.7%)
 
Grade III
10 (4.1%)
 
Unknown
21 (8.7%)
Duration of adjuvant endocrine therapy (months)
Median (SD)
26.7 (19.1) mo.
 
Range
0.7- 89.5 mo.
Primary surgical treatment
Breast-conserving procedure
155 (65.7%)
 
Mastectomy
81 (34.3%)
 
Reconstruction
43 (18.2%)
Chemotherapy
 
41 (16.9%)
Radiotherapy   169 (71.3%)